|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 410 JPY | +2.50% |
|
+5.40% | -12.02% |
| Apr. 22 | Lull in Geopolitical Tensions Lifts Asian Stock Markets | MT |
| Apr. 17 | Jefferies Adjusts Sumitomo Pharma’s Price Target to 420 Yen From 520 Yen, Keeps at Hold | MT |
Oct 23 (Reuters) - Sumitovant Biopharma Ltd, along with parent Sumitomo Pharma Co Ltd, has entered into a deal to purchase all shares of Myovant Sciences not already owned by Sumitovant for $27 per share, the companies said in a statement on Sunday. (Reporting by Ann Maria Shibu in Bengaluru; Editing by Shailesh Kuber)
| 1st Jan change | Capi. | |
|---|---|---|
| -12.02% | 1.03B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
SUMITOMO PHARMA CO., LTD. 
